Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs

Treatment to ameliorate the symptoms of infection with herpes simplex virus 2 (HSV-2) and to suppress reactivation has been available for decades. However, a safe and effective preventative or therapeutic vaccine has eluded development. Two novel live-attenuated HSV-2 vaccine candidates (RVx201 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyce, Jonathan D., Patel, Anant K., Murphy, Brandie, Carr, Daniel J.J., Gershburg, Edward, Bertke, Andrea S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999511/
https://www.ncbi.nlm.nih.gov/pubmed/33805768
http://dx.doi.org/10.3390/vaccines9030258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999511/
https://www.ncbi.nlm.nih.gov/pubmed/33805768
http://dx.doi.org/10.3390/vaccines9030258

Ejemplares similares